Cancer Research Cancer Epigenetics Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dallol, A.
Right arrow Articles by Latif, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dallol, A.
Right arrow Articles by Latif, F.
[Cancer Research 63, 1054-1058, March 1, 2003]
© 2003 American Association for Cancer Research

Molecular Biology and Genetics

SLIT2 Axon Guidance Molecule Is Frequently Inactivated in Colorectal Cancer and Suppresses Growth of Colorectal Carcinoma Cells1

Ashraf Dallol, Dion Morton, Eamonn R. Maher and Farida Latif2

Section of Medical and Molecular Genetics, Division of Reproductive and Child Health [A. D., E. R. M., F. L.], and Department of Surgery [D. M.], University of Birmingham, Birmingham B15 2TT, United Kingdom, and Cancer Research United Kingdom, Renal Molecular Oncology Research Group, University of Birmingham, Birmingham B15 2TT, United Kingdom [E. R. M., F. L.]

We have shown recently that SLIT2 has tumor suppressor activity and that it is epigenetically silenced in >40% of lung and breast tumors. In this study, we have analyzed the methylation status of SLIT2 in primary colorectal cancers and matching normal colorectal mucosa. SLIT2 promoter region methylation was found in 23 (72%) of 32 primary colorectal cancers. In contrast, normal colorectal mucosa from the same patients exhibited significantly lower levels of SLIT2 promoter region hypermethylation. SLIT2 methylation was reversed and expression restored by treating colorectal tumor cell lines with the demethylating agent 5-aza-2-deoxycytidine. Loss of heterozygosity at D4S1546 marker, which maps within 100 kb of the SLIT2 gene, was observed in 39% of the methylated tumors. Furthermore, SLIT2 epigenetic silencing was independent of ROBO1/p16/RASSF1A hypermethylation. The presence of SLIT2 methylation was also independent of the presence of K-RAS mutations. Ectopic expression of SLIT2 diminished the ability to form colonies in two colorectal tumor cell lines. In addition, conditioned medium from SLIT2-transfected COS-7 cells reduced cell growth and induced apoptosis in SW48 colorectal tumor cell line. In conclusion, SLIT2 is an excellent candidate tumor suppressor gene for colorectal cancer.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Yuasa-Kawada, M. Kinoshita-Kawada, Y. Rao, and J. Y. Wu
Deubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration
PNAS, August 25, 2009; 106(34): 14530 - 14535.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
M. C. Stella, L. Trusolino, and P. M. Comoglio
The Slit/Robo System Suppresses Hepatocyte Growth Factor-dependent Invasion and Morphogenesis
Mol. Biol. Cell, January 1, 2009; 20(2): 642 - 657.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. E. Dickinson, M. Myers, and W. C. Duncan
Novel Regulated Expression of the SLIT/ROBO Pathway in the Ovary: Possible Role during Luteolysis in Women
Endocrinology, October 1, 2008; 149(10): 5024 - 5034.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Prasad, V. Paruchuri, A. Preet, F. Latif, and R. K. Ganju
Slit-2 Induces a Tumor-suppressive Effect by Regulating {beta}-Catenin in Breast Cancer Cells
J. Biol. Chem., September 26, 2008; 283(39): 26624 - 26633.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Ito, S.-i. Funahashi, N. Yamauchi, J. Shibahara, Y. Midorikawa, S. Kawai, Y. Kinoshita, A. Watanabe, Y. Hippo, T. Ohtomo, et al.
Identification of ROBO1 as a Novel Hepatocellular Carcinoma Antigen and a Potential Therapeutic and Diagnostic Target.
Clin. Cancer Res., June 1, 2006; 12(11): 3257 - 3264.
[Abstract] [Full Text] [PDF]

Home page
 Vasc MedHome page
M. Fujiwara, M. Ghazizadeh, and O. Kawanami
Potential role of the Slit/Robo signal pathway in angiogenesis
Vascular Medicine, May 1, 2006; 11(2): 69 - 74.
[Abstract] [PDF]

Home page
 Cancer Res.Home page
J. Xian, A. Aitchison, L. Bobrow, G. Corbett, R. Pannell, T. Rabbitts, and P. Rabbitts
Targeted Disruption of the 3p12 Gene, Dutt1/Robo1, Predisposes Mice to Lung Adenocarcinomas and Lymphomas with Methylation of the Gene Promoter
Cancer Res., September 15, 2004; 64(18): 6432 - 6437.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
K. T. Nguyen-Ba-Charvet, N. Picard-Riera, M. Tessier-Lavigne, A. Baron-Van Evercooren, C. Sotelo, and A. Chedotal
Multiple Roles for Slits in the Control of Cell Migration in the Rostral Migratory Stream
J. Neurosci., February 11, 2004; 24(6): 1497 - 1506.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.